Quotes

Back To Menu

Dr Lal Pathlabs Ltd NSE  /  BSE

Healthcare, Mid Cap

Invest

03 Jul 2020 | 03:59 PM

1,618.70
46.70 (2.97%)

  • Outperforms Index

    50.55%

    Return (1Y)

    Beaten S&P BSE Healthcare by 24.21%

  • More Volatile

    2.61%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.05%

  • Not so consistent

    6/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,846

1,845.90

1,038

1,037.60

News & Announcements

  • Dr Lal Pathlabs consolidated net profit declines 31.00% in the March 2020 quarter

    48 days ago

  • Dr Lal Pathlabs standalone net profit declines 23.26% in the March 2020 quarter

    48 days ago

  • Dr. Lal PathLabs schedules board meeting

    58 days ago

  • Dr Lal Pathlabs receives credit ratings for bank facilities

    79 days ago

Price vs Volume

Stock Trivia

  • Dr Lal Pathlabs Ltd has topped the 3 years performance among stocks in Healthcare Sector

  • FII shareholding in Dr Lal Pathlabs Ltd has increased by 12.77% since past 1 Year

  • MF shareholding in Dr Lal Pathlabs Ltd has increased by 15.25% since past 1 Year

  • Dr Lal Pathlabs Ltd has the 3rd highest P/E ratio according to FY202003 data among stocks in Healthcare Sector

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...